bioRxiv · 10.1101/2023.01.30.524522
p16-dependent upregulation of PD-L1 impairs immunosurveillance of senescent cells
Abstract
The accumulation of senescent cells promotes aging, but a molecular mechanism that senescent cells use to evade immune clearance and accumulate remains to be elucidated. Here, we report that p16-positive senescent cells upregulate the immune checkpoint protein programmed death-ligand 1 (PD-L1) to accumulate in aging and chronic inflammation. p16-mediated inhibition of CDK4/6 promotes PD-L1 stability in senescent cells via the downregulation of ubiquitin-dependent degradation. p16 expression in infiltrating macrophages induces an immunosuppressive environment that can contribute to an increased burden of senescent cells. Treatment with immunostimulatory anti-PD-L1 antibody enhances the cytotoxic T cell activity and leads to the elimination of p16, PD-L1-positive cells. Our study uncovers a molecular mechanism of p16-dependent regulation of PD-L1 protein stability in senescent cells and reveals the potential of PD-L1 as a target for treating senescence-mediated age-associated diseases.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Majewska, J., Agrawal, A., Mayo, A., Roitman, L., Chatterjee, R., Kralova, J., Landsberger, T., Katzenelenbogen, Y., Salame, T. M., Hagai, E., Stanojevic, N., Amit, I., Alon, U., Krizhanovsky, V.. 2023-02-01. p16-dependent upregulation of PD-L1 impairs immunosurveillance of senescent cells. https://doi.org/10.1101/2023.01.30.524522
Cite the original work for its findings. Save a collection to share your selection of sources.